Skip to content
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
Company
Companies

Towa Pharmaceutical

東和薬品

4553 · TSE · Pharmaceutical · 1 article

Financials Consolidated

Revenue¥274bn+5.4% year on yearConsolidated · FY3/26

Ordinary profit¥28.1bn+7.4% year on yearConsolidated · FY3/26

Net profit¥5.25bn−72.3% year on yearConsolidated · FY3/26

Dividend per share¥80.00FY3/26

Performance over time

Revenue
¥166bnFY3/22
¥209bnFY3/23
¥228bnFY3/24
¥260bnFY3/25
¥274bnFY3/26
Ordinary profit
¥22.7bnFY3/22
¥5.14bnFY3/23
¥24.5bnFY3/24
¥26.2bnFY3/25
¥28.1bnFY3/26
Net profit (attributable)
¥15.9bnFY3/22
¥2.20bnFY3/23
¥16.2bnFY3/24
¥19.0bnFY3/25
¥5.25bnFY3/26
Op. cash flow
¥22.1bnFY3/22
¥2.54bnFY3/23
¥8.21bnFY3/24
¥23.4bnFY3/25
¥30.4bnFY3/26

People & pay

Employees, whole group4,923 peopleFY3/26

Employees, parent company (non-consolidated)2,899 peopleFY3/26

Average salary¥6.95mFY3/26

Average salary is for the parent company's own employees (non-consolidated), as Japanese annual reports disclose it.

Five-year history
Five-year history
Fiscal yearRevenueOrdinary profitNet profit (attributable)EPSDividendTotal assetsNet assetsOp. cash flow
FY3/26¥274bn+5.4% year on year¥28.08bn¥5.25bn¥106.66¥80.00¥475bn¥178bn¥30.43bn
FY3/25¥260bn+13.9% year on year¥26.15bn¥18.99bn¥385.71¥70.00¥471bn¥172bn¥23.40bn
FY3/24¥228bn+9.1% year on year¥24.48bn¥16.17bn¥328.59¥60.00¥431bn¥156bn¥8.21bn
FY3/23¥209bn+26.1% year on year¥5.14bn¥2.20bn¥44.72¥60.00¥371bn¥137bn¥2.54bn
FY3/22¥166bn¥22.74bn¥15.91bn¥323.36¥60.00¥332bn¥132bn¥22.13bn

Per-share figures are as each report states them: a share split is restated only for the year before it, and dividends are as paid.

Figures from annual report S100YFVM · Japan GAAP. Each figure's years come from one report's five-year summary.

Latest coverage

TSE:4553

Tokyo Brief coverage

All articles loaded · 1 shown

AGM votes

This season’s shareholder voting results.

1 meeting · data through

AGM votes
ProposalApprovalResultFiling
Appropriation of surplus
Original (Japanese)剰余金処分の件
98.66%Votes cast: 99.91%ApprovedFiled  — filing S100YLTV
Amendment of articles
Original (Japanese)定款一部変更の件
98.64%Votes cast: 99.89%ApprovedFiled  — filing S100YLTV
Matter of issuance of Class A preferred shares via third-party allotmentMachine translated
Original (Japanese)第三者割当によるA種優先株式発行の件
98.62%Votes cast: 99.87%ApprovedFiled  — filing S100YLTV
Proposal 4: Election of 6 directors (excluding audit committee directors)
Original (Japanese)第4号議案 取締役(監査等委員である取締役を除く。)6名選任の件
· 吉田 逸郎
80.91%Votes cast: 81.93%ApprovedFiled  — filing S100YLTV
Proposal 4: Election of 6 directors (excluding audit committee directors)
Original (Japanese)第4号議案 取締役(監査等委員である取締役を除く。)6名選任の件
· 内川 治
95.99%Votes cast: 97.21%ApprovedFiled  — filing S100YLTV
Show 8 more meetings (13 total)
AGM votes
ProposalApprovalResultFiling
Proposal 4: Election of 6 directors (excluding audit committee directors)
Original (Japanese)第4号議案 取締役(監査等委員である取締役を除く。)6名選任の件
· 國分 俊和
96.01%Votes cast: 97.23%ApprovedFiled  — filing S100YLTV
Proposal 4: Election of 6 directors (excluding audit committee directors)
Original (Japanese)第4号議案 取締役(監査等委員である取締役を除く。)6名選任の件
· 竹安 正顕
96.01%Votes cast: 97.23%ApprovedFiled  — filing S100YLTV
Proposal 4: Election of 6 directors (excluding audit committee directors)
Original (Japanese)第4号議案 取締役(監査等委員である取締役を除く。)6名選任の件
· 中村 豪之
96.01%Votes cast: 97.22%ApprovedFiled  — filing S100YLTV
Proposal 4: Election of 6 directors (excluding audit committee directors)
Original (Japanese)第4号議案 取締役(監査等委員である取締役を除く。)6名選任の件
· 栄木 憲和
94.32%Votes cast: 95.52%ApprovedFiled  — filing S100YLTV
Proposal 5: Election of 4 audit committee directors
Original (Japanese)第5号議案 監査等委員である取締役4名選任の件
· 田中 政男
90.68%Votes cast: 91.83%ApprovedFiled  — filing S100YLTV
Proposal 5: Election of 4 audit committee directors
Original (Japanese)第5号議案 監査等委員である取締役4名選任の件
· 大石 歌織
97.53%Votes cast: 98.77%ApprovedFiled  — filing S100YLTV
Proposal 5: Election of 4 audit committee directors
Original (Japanese)第5号議案 監査等委員である取締役4名選任の件
· 安藤 伸樹
95.76%Votes cast: 96.98%ApprovedFiled  — filing S100YLTV
Proposal 5: Election of 4 audit committee directors
Original (Japanese)第5号議案 監査等委員である取締役4名選任の件
· 谷口 宗哉
89.39%Votes cast: 90.52%ApprovedFiled  — filing S100YLTV

Approval is the ratio the company states (usually of the voting rights of shareholders present); votes cast are for ÷ (for + against + abstain).

† Percentage of votes cast; company did not state a ratio.

† Company-stated ratio differs from tallied votes.

Cross-holdings

Strategic shareholdings and sales, by fiscal year.

6 fiscal years · data through

Balance-sheet value
¥275mFY3/22
¥267mFY3/23
¥386mFY3/24
¥444mFY3/25
¥582mFY3/26

Balance-sheet value is the reporting company's own listed holdings (its largest holding subsidiary's where marked), carried at market value; the percentage divides it by consolidated net assets in the same annual report.

Cross-holdings
Fiscal year endHoldings (issuers)Balance-sheet value% of consolidated net assetsIssues cutSale proceedsFiling
31 Mar 20263¥582m0.33%——Filed  — filing S100YFVM
Show 5 more fiscal years (6 total)
Cross-holdings
Fiscal year endHoldings (issuers)Balance-sheet value% of consolidated net assetsIssues cutSale proceedsFiling
31 Mar 20253¥444m0.26%——Filed  — filing S100W349
31 Mar 20243¥386m0.25%——Filed  — filing S100U0TC
31 Mar 20233¥267m0.20%——Filed  — filing S100R6JN
31 Mar 20223¥275m0.21%——Filed  — filing S100OFJU
31 Mar 20213¥291m0.25%——Filed  — filing S100LQXR

Fund positioning

Current holdings disclosed by tracked funds.

21 funds · data through

Held by 21 tracked funds; largest weight 3.36%. Holdings as of 31 Jul 2026–20 Nov 2026.

Show 11 more funds (21 total)